Quality Oncology Practice Initiative (QOPI®) Certification Program

Sparrow Medical Oncology has become one of the first oncology practices in the nation to be recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO). The QOPI® Certification Program is a new initiative to certify oncology practices that meet rigorous standards for high-quality cancer care.

QOPI is a voluntary, self-assessment and improvement program launched by ASCO in 2006 to help hematology-oncology and medical oncology practices assess the quality of the care they provide to patients. Through the QOPI programs, practices abstract data from patients’ records up to twice per year and enter this information into a secure database. Sparrow Medical Oncology is one of 23 receiving the inaugural certification in 2010.

More than 580 oncology practices have registered in the QOPI program. QOPI analyzes individual practice data and compares these to more than 80 evidence-based and consensus quality measures. The information is then provided in reports to participating practices. Individual practices are also able to compare their performance to data from other practices across the country. Based on this feedback, doctors and practices can identify areas for improvement. The QOPI Certification Program provides a three-year certification for outpatient hematology-oncology practices that meet standards for quality cancer care. The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 28,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals.

For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.cancer.net.

Commission on Cancer (CoC) Accreditation Program

A Commission on Cancer-Accredited Cancer Program.

Sparrow Cancer Center has been fully accredited with Commendation by the Commission on Cancer. Only 14 percent of all accredited Cancer Centers achieve this status.

The Commission on Cancer (CoC) Accreditation Program encourages hospitals, treatment centers, and other facilities to improve their quality of patient care through various cancer-related programs. These programs focus on prevention, early diagnosis, pretreatment evaluation, staging, optimal treatment, rehabilitation, and surveillance for recurrent disease, support services, and end-of-life care. The availability of a full range of medical services along with a multidisciplinary team approach to patient care at accredited cancer programs has resulted in approximately 80 percent of all newly diagnosed cancer patients being treated in CoC-accredited cancer programs. Recognizing that cancer is a complex group of diseases, the CoC Cancer Program Standards promote consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists. This multidisciplinary cooperation results in improved patient care.

Michigan Breast Oncology Quality Initiative (MiBOQI)

Sparrow Cancer Center is one of a number of select Cancer Centers to participate in the Michigan Breast Oncology Quality Initiative. Along with Blue Cross and the University of Michigan, the Cancer Center works collaboratively to improve care for breast cancer patients. This effort leads the way in defining what are the best evidence-based treatments for breast cancer and making sure that all our patients receive these treatments.

Continuing Education

Our physicians believe that continuing education is essential to the service and quality of care we provide our patients. We host a weekly educational seminar from September through May, bringing in physicians from all over the United States on various cancer-related topics. The program is for all medical professionals throughout Sparrow to further their knowledge on the offered topics. We also host multiple tumor boards on a monthly, bi-weekly, and weekly basis. The purpose of these tumor boards is to discuss patient cases with a variety of specialists, to further physician knowledge, and to decide on best treatment options with multiple oncologist, surgeon, pathologist, and radiologist input. We have the following tumor boards: General Tumor Board, GYN Tumor Board, Head & Neck Tumor Board, Neuro-Oncology Tumor Board, Gastro-Intestinal Tumor Board and the Hematopathology Conference.